Interpretation Of Maiwei Biotech's 2025 Annual Report: Revenue Increases, Losses Decrease, R&D Investment Is High, And There Are Many Varieties
On March 24, Maiwei Biotech announced its 2025 annual report. The company's operating income was 663 million yuan, a year-on-year increase of 231.6%; the net profit attributable to the parent company increased from a loss of 1.04 billion yuan in the same period last year to a loss of 969 million yuan.


















